Marshall Posner, MD
img_Marshall Posner
PROFESSOR | Medicine, Hematology and Medical Oncology
PROFESSOR | Otolaryngology
Are you a patient?
Specialties
Cancer (Oncology), Internal Medicine
Research Topics
Anti-Tumor Therapy, Antibody Development, Antivirals, Cancer, Cellular Immunity, Immunology, Tumorigenesis, Viruses and Virology
HPV and Human Oropharyngeal Cancer
Translational studies to understand the biology and immunology of HPV related oropharyngeal cancer in order to inform therapeutic and preventative therapies in this disease.
Clinical Studies in Head and Neck Cancer
Development of curative therapeutics for patients with HPV positive and negative head and neck cancer, through clinical trials, drug development and translational studies using conventional chemotherapy, novel biotherapeutics vaccines and gene therapies.

MD, Tufts University School of Medicine

Residency, Internal Medicine, CentraCare - Benson Hospital

Fellowship, Medical Oncology, Dana-Farber Cancer Institute

Certifications

American Board of Internal Medicine

2007

Ninth Warton Visiting Professor, Prince Margaret Hospital

2007

Tisch Award for Clinical Research, Dana-Farber Cancer Institute

1975

Alpha Omega Alpha, Medical Honor Society

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Posner during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Calliditas Therapeutics AB
  • Merck Sharp & Dohme Corp
  • Frizent
  • Merus N.V.
  • Galera Therapeutics Inc.
  • Vivant Therapeutics

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.